Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Alector Inc (ALEC)

Alector Inc (ALEC)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,613,965
  • Shares Outstanding, K 79,767
  • Annual Sales, $ 21,100 K
  • Annual Income, $ -190,230 K
  • 60-Month Beta 1.04
  • Price/Sales 120.08
  • Price/Cash Flow N/A
  • Price/Book 10.60
Trade ALEC with:

Options Overview

Details
  • Implied Volatility 114.25%
  • Historical Volatility 172.76%
  • IV Percentile 55%
  • IV Rank 24.20%
  • IV High 219.76% on 11/10/20
  • IV Low 80.57% on 06/11/21
  • Put/Call Vol Ratio 0.16
  • Today's Volume 540
  • Volume Avg (30-Day) 2,444
  • Put/Call OI Ratio 0.71
  • Today's Open Interest 14,827
  • Open Int (30-Day) 15,118

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate -0.69
  • Number of Estimates 5
  • High Estimate -0.62
  • Low Estimate -0.77
  • Prior Year -0.58
  • Growth Rate Est. (year over year) -18.97%

Price Performance

See More
Period Period Low Period High Performance
1-Month
20.37 +60.87%
on 06/30/21
43.32 -24.35%
on 07/02/21
+11.91 (+57.09%)
since 06/23/21
3-Month
15.04 +117.89%
on 05/13/21
43.32 -24.35%
on 07/02/21
+14.01 (+74.68%)
since 04/23/21
52-Week
9.12 +259.32%
on 10/30/20
43.32 -24.35%
on 07/02/21
+10.48 (+47.02%)
since 07/23/20

Most Recent Stories

More News
Alector to Present New Data from Frontotemporal Dementia and Alzheimer's Disease Programs at the 2021 Alzheimer's Association International Conference

Oral Presentation to Highlight Data from the Ongoing Phase 2 Study of AL001 in FTD-GRN

ALEC : 32.77 (+3.18%)
Alector's (ALEC) Shares March Higher, Can It Continue?

As of late, it has definitely been a great time to be an investor in Alector, Inc. (ALEC).

ALEC : 32.77 (+3.18%)
Pharma Stock Roundup: GSK's New Deal With Alector, MRK & AZN's FDA Updates

Glaxo (GSK) to co-develop Alector's two candidates for neurodegenerative diseases. FDA updates for Merck (MRK) and AstraZeneca (AZN)

AZN : 58.23 (+0.47%)
GSK : 39.51 (+0.71%)
MRK : 77.54 (+1.32%)
LLY : 244.15 (+2.37%)
AMGN : 247.72 (+1.22%)
ALEC : 32.77 (+3.18%)
Biotech Stock Roundup: ALEC Surges on Deal With GSK, CVAC Down on Study Results & More

The biotech sector was in focus last week on the collaboration news from Alector (ALEC) and pipeline updates from CureVac (CVAC).

GSK : 39.51 (+0.71%)
PFE : 41.68 (+0.51%)
SPRO : 14.33 (-0.83%)
ALEC : 32.77 (+3.18%)
CVAC : 54.17 (-1.65%)
KTRA : 1.63 (-2.98%)
Alector (ALEC) Up on Tie-Up With Glaxo for Neurological Diseases

Alector (ALEC) signs a global collaboration deal with Glaxo to co-develop/commercialize two monoclonal antibodies - AL001 and AL101 ??? for treating various neurodegenerative diseases. Stock up.

GSK : 39.51 (+0.71%)
RGEN : 209.92 (+1.90%)
TRVN : 1.47 (-5.77%)
ALEC : 32.77 (+3.18%)
Glaxo (GSK)/Alector Ink Deal for Neurodegenerative Indications

Glaxo (GSK) and Alector set to co-develop and co-commercialize AL001 and AL101 for neurodegenerative diseases. Glaxo issues a formal response to activist hedge investor, Elliott's call for board changes....

GSK : 39.51 (+0.71%)
BAYRY : 14.9700 (-0.20%)
ALEC : 32.77 (+3.18%)
ITOS : 24.32 (-3.26%)
Alector (ALEC) Stock Jumps 57.1%: Will It Continue to Soar?

Alector (ALEC) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

ALEC : 32.77 (+3.18%)
Alector, Virgin Galactic rise; Arrowhead, Boeing fall

Stocks that traded heavily or had substantial price changes Friday:

TSLA : 643.38 (-0.91%)
ARWR : 68.37 (+0.66%)
ALEC : 32.77 (+3.18%)
C : 66.71 (-0.33%)
BA : 221.52 (+0.29%)
Thinking about trading options or stock in Alector, Alibaba, Sony, Exxon Mobil, or Nio?

/PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ALEC, BABA, SONY, XOM, and NIO.

ALEC : 32.77 (+3.18%)
BABA : 206.53 (-3.51%)
NIO : 43.99 (-4.51%)
SONY : 100.66 (+1.14%)
XOM : 57.04 (-0.12%)
Alector and GSK announce global collaboration in immuno-neurology for two clinical stage first-in-class monoclonal antibodies for neurodegenerative diseases

-- Alector management to host conference call today at 8:30 a.m. ET

ALEC : 32.77 (+3.18%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Alector Inc. is a clinical stage biotechnology company pioneering immuno-neurology, a novel therapeutic approach for the treatment of neurodegenerative diseases. Its product portfolio includes AL001, AL101, Al002 and AL003 which are in clinical stage. Alector Inc. is headquartered in South San Francisco,...

See More

Key Turning Points

3rd Resistance Point 35.75
2nd Resistance Point 34.45
1st Resistance Point 33.61
Last Price 32.77
1st Support Level 31.47
2nd Support Level 30.17
3rd Support Level 29.33

See More

52-Week High 43.32
Last Price 32.77
Fibonacci 61.8% 30.26
Fibonacci 50% 26.22
Fibonacci 38.2% 22.18
52-Week Low 9.12

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar